• Population: Community based hospice
• Outcome: Median Survival in days
• Scroll to the bottom for more detailed information.

• The Palliative Performance Scale (PPS) has been shown to be both valid and useful for a broad range of palliative care patients: those with advanced cancer diagnoses or life-threatening non-cancer diagnoses in clinics, hospitals, or hospices.
• The PPS scale¹ was developed in 119 palliative care patients at home (73% with PPS rating between 40-70%) and 213 patients admitted to a hospice unit (83% with PPS rating between 20-50% on admission) in Victoria, British Columbia.
• This scale² was externally validated by looking at 396 patients admitted to a large community based hospice program with a stay of at least 5 days (mean age of 72.2 years, 46% male, mean admission PPS score 38.9).
• Discrimination: The PPS was not highly discriminating between the 30% to 40% scores or the 50% to 70% scores in the external validation.
• Calibration: Calibration was not assessed.
• Citations:
  1. Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative Performance scale (PPS): a new tool. J Pall Care, 12(1): 5-11
  2. Head B, Ritchie CS, Smoot TM. Prognostication in Hospice Care: Can the Palliative Performance Scale Help? J Pall Med. 2005; 8(3): 492-502

The information provided on ePrognosis is designed to complement, not replace, the relationship between a patient and his/her own medical providers. ePrognosis was created with the support of the Division of Geriatrics at the University of California San Francisco. However, its content is strictly the work of its authors and has no affiliation with any organization or institution. This web site does not accept advertisements. If you reproduce the material on the website please cite appropriately. For feedback and questions regarding the site please email Sei Lee, MD (sei.lee@ucsf.edu), Alex Smith, MD (aksmith@ucsf.edu) or Eric Widera, MD (eric.widera@ucsf.edu).